Analytical Data
-
Gene name
TNFAIP8L1
- Application
-
Alternative Names
TNFAIP8L1; Tumor necrosis factor alpha-induced Protein 8-like Protein 1; TIPE1; TNF alpha-induced Protein 8-like Protein 1; TNFAIP8-like Protein 1; Oxidative stress-regulated gene-beta; Oxy-beta
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8WVP5
-
Expression Region
1-186 aa
-
AA Sequence
MDTFSTKSLA LQAQKKLLSK MASKAVVAVL VDDTSSEVLD ELYRATREFT RSRKEAQKML KNLVKVALKL GLLLRGDQLG GEELALLRRF RHRARCLAMT AVSFHQVDFT FDRRVLAAGL LECRDLLHQA VGPHLTAKSH GRINHVFGHL ADCDFLAALY GPAEPYRSHL RRICEGLGRM LDEGSL
-
Molecular Weight
20.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TNFAIP8L1, also known as TNF-alpha-induced protein 8-like 1, is a member of the TNFα-induced protein family and has garnered attention in recent years due to its potential roles in immune regulation and cancer progression. This protein is thought to be involved in various cellular processes, including apoptosis, inflammation, and cell survival, making it a significant factor in both innate and adaptive immune responses. Research has indicated that TNFAIP8L1 may play a crucial role in modulating immune system functions, particularly in the context of autoimmune diseases and tumor development. Elevated levels of TNFAIP8L1 have been observed in several malignancies, suggesting a possible role in promoting tumor cell growth and survival, thereby highlighting its potential as a therapeutic target. The study of TNFAIP8L1 recombinant protein offers a pathway to better understand its biological functions and mechanisms of action. By producing the protein in a controlled laboratory setting, researchers can investigate its structural characteristics, interactions with other cellular molecules, and its downstream effects on signaling pathways, thus facilitating the development of targeted therapies. Overall, ongoing research into TNFAIP8L1 aims to clarify its roles in disease pathology and explores its potential implications in therapeutic interventions for cancer and immune-related disorders.
